美國的D2C (消費者直接交易) 遺傳基因檢驗市場 (2023年～2032年):市場規模 (各檢驗、技術、流通管道)、用途的潛在性、競爭市場佔有率、預測

U.S. Direct-to-Consumer Genetic Testing Market Size By Test, By Technology, By Distribution Channel, Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023 - 2032

出版日期: 2023年01月19日 | 出版商:

Global Market Insights Inc. | 英文 60 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

美國的D2C (消費者直接交易) 遺傳基因檢驗的市場，預計從2023年到2032年顯示大幅度的成長。

遺傳性疾病相關認識度的提高，提供個性化的健康資訊，增加健康積極性，廉價等，DTC遺傳基因檢驗相關的幾個優點，今後數年更加刺激其需求。

各技術中，標的分析的部門2022年顯示5億4,200萬美元以上的規模。還有各銷售管道上，預計從2023年到2032年OTC的部門提高大幅利益。

本報告提供美國的D2C (消費者直接交易) 遺傳基因檢驗的市場調查，市場概要，市場成長的各種影響因素分析，法律規章、償付環境，技術形勢，市場規模的變化、預測，各種區分的明細，競爭環境，主要企業簡介等彙整資訊。

23andMe, Inc.
Ancestry
Counsyl
Easy DNA
HomeDNA
Family Tree DNA(Gene By Gene)
Full Genome Corporation Inc.
Helix OpCo LLC
Identigene, Inc.
Karmagenes SA
Living DNA Ltd.
MyHeritage Ltd.
Pathway genomics
Genesis Healthcare Co.
The SkinDNA Company Pty Ltd
Ambry Genetics
Blueprint Genetics Oy
DNA Genotek Inc.
Dante Lab
DNA Diagnostic Center

簡介目錄圖表

Product Code: 4368

U.S. Direct-to-Consumer (DTC) Genetic Testing Market is expected to demonstrate substantial growth from 2023 to 2032. DTC genetic testing offers people access to genetic information without involving a healthcare provider or health insurance company. Besides, several benefits associated with DTC genetics, such as promoting awareness regarding genetic diseases, offering personalized health information, making people more proactive about their health, and being less expensive, are anticipated to further stimulate its demand in the coming years.

In addition, the U.S. DTC genetic testing market is anticipated to increase owing to the growing prevalence of rare genetic diseases. Moreover, technological innovations in the healthcare industry are also anticipated to foster the demand for DTC genetic testing. The constantly growing investments made in the healthcare infrastructure in the U.S. and the high accuracy & efficiency possessed by DTC genetic tests will surge the demand and prove beneficial for industry growth over the foreseeable period.

Conglomerates working in the U.S. direct-to-consumer (DTC) industry are persistently taking strategic initiatives to gain a competitive advantage in the overall market. To cite an instance, in January 2021, myDNA merged with Gene by Gene and FamilyTreeDNA. The two businesses have amalgamated to become one of the leading global experts in genealogy, pharmacogenomic and nutrigenomic services. Besides, the merger is grounded on several shared beliefs about the tremendous potential of genetic information.

Overall, the U.S. direct-to-consumer (DTC) genetic testing industry is segmented in terms of test type, technology, and distribution channel.

Based on test type, the carrier testing segment is anticipated to experience robust growth through 2032, primarily due to the increasing cases of rare genetic diseases. Carrier testing determines if an individual carries a genetic variation (allele) related to a specific disease or trait. The landscape of rare diseases is constantly changing as new rare conditions or diseases are regularly identified and reported, which is anticipated to help the segment grow in the coming years.

By technology, the targeted analysis segment was valued at over USD 542 million in 2022. The targeted analysis determines the defects in genes that cause disorders. Besides, targeted genotyping empowers researchers to focus more on specific regions of interest, generates a smaller and more manageable dataset, reduces data analysis burden, and offers a cost-efficient solution with decreased turnaround time compared to broader approaches.

On the basis of distribution channel, over-the-counter segment is anticipated to amass considerable gains during 2023-2032. DTC genetic testing devices and drugs available over the counter enable people to self-treat without the need for prescription, while saving health systems valuable resources and consumers' money and time.

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at country level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1.1 Business trends

Chapter 3 US Direct-To-Consumer (DTC) Genetic Testing Industry Insights

3.1 Industry landscape, 2018 - 2032
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising public awareness regarding DTC genetic tests
  - 3.2.1.2 Increasing demand for personalized DTC genetic services
  - 3.2.1.3 Rising incidences of genetic disorders
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Defects in the DTC testing
  - 3.2.2.2 Data privacy concerns associated with DTC genetic testing
3.3 Growth potential analysis
- 3.3.1 By test type
- 3.3.2 By technology
- 3.3.3 By distribution channel
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Future market trends
3.7 Regulatory landscape
3.8 Value chain analysis
3.9 Data privacy concerns
3.10 U.S. DTC genetic testing - pricing analysis, 2021
3.11 Reimbursement scenario
3.12 Porter's analysis
3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Company market share analysis, 2021
4.4 Strategy dashboard, 2021

Chapter 5 US Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type

5.1 Key segment trends
5.2 Carrier testing
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.3 Predictive testing
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.4 Ancestry & Relationship Testing
- 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.5 Nutrigenomics Testing
- 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.6 Skincare Testing
- 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.7 Others
- 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)

Chapter 6 US Direct-To-Consumer (DTC) Genetic Testing Market, By Technology

6.1 Key segment trends
6.2 Targeted analysis
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Single nucleotide polymorphism (SNP) chips
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Whole genome sequencing [WGS]
- 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 US Direct-To-Consumer (DTC) Genetic Testing Market, By Distribution Channel

7.1 Key segment trends
7.2 Online platforms
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Over-the-Counter
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

8.1 23andMe, Inc.
8.2 Ancestry
8.3 Counsyl
8.4 Easy DNA
8.5 HomeDNA
8.6 Family Tree DNA (Gene By Gene)
8.7 Full Genome Corporation Inc.
8.8 Helix OpCo LLC
8.9 Identigene, Inc.
8.10 Karmagenes SA
8.11 Living DNA Ltd.
8.12 MyHeritage Ltd.
8.13 Pathway genomics
8.14 Genesis Healthcare Co.
8.15 The SkinDNA Company Pty Ltd
8.16 Ambry Genetics
8.17 Blueprint Genetics Oy
8.18 DNA Genotek Inc.
8.19 Dante Lab
8.20 DNA Diagnostic Center

簡介目錄圖表

Data Tables

TABLE 1. Product mapping
TABLE 2. Market revenue, by test type (2022)
TABLE 3. Market revenue, by technology (2022)
TABLE 4. Market share, by distribution channel (2022)
TABLE 5. U.S. direct-To-Consumer (DTC) genetic testing market, 2018 - 2024 (USD Million)
TABLE 6. U.S. direct-To-Consumer (DTC) genetic testing market, 2025 - 2032 (USD Million)
TABLE 7. U.S. direct-To-Consumer (DTC) genetic testing market, 2018 - 2024 (Units)
TABLE 8. U.S. direct-To-Consumer (DTC) genetic testing market, 2025 - 2032 (Units)
TABLE 9. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2018 - 2024 (USD Million)
TABLE 10. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2025 - 2032 (USD Million)
TABLE 11. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2018 - 2024 (Units)
TABLE 12. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2025 - 2032 (Units)
TABLE 13. U.S. direct-To-Consumer (DTC) genetic testing market, by technology, 2018 - 2024 (USD Million)
TABLE 14. U.S. direct-To-Consumer (DTC) genetic testing market, by technology, 2025 - 2032 (USD Million)
TABLE 15. U.S. direct-To-Consumer (DTC) genetic testing market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 16. U.S. direct-To-Consumer (DTC) genetic testing market, by distribution channel, 2025 - 2032 (USD Million)
TABLE 17. Industry impact forces
TABLE 18. Carrier testing market, 2018 - 2024 (USD Million)
TABLE 19. Carrier testing market, 2025 - 2032 (USD Million)
TABLE 20. Carrier testing market, 2018 - 2024 (Units)
TABLE 21. Carrier testing market, 2025 - 2032 (Units)
TABLE 22. Predictive testing market, 2018 - 2024 (USD Million)
TABLE 23. Predictive testing market, 2025 - 2032 (USD Million)
TABLE 24. Predictive testing market, 2018 - 2024 (Units)
TABLE 25. Predictive testing market, 2025 - 2032 (Units)
TABLE 26. Ancestry & relationship testing market, 2018 - 2024 (USD Million)
TABLE 27. Ancestry & relationship testing market, 2025 - 2032 (USD Million)
TABLE 28. Ancestry & relationship testing market, 2018 - 2024 (Units)
TABLE 29. Ancestry & relationship testing market, 2025 - 2032 (Units)
TABLE 30. Nutrigenomics testing market, 2018 - 2024 (USD Million)
TABLE 31. Nutrigenomics testing market, 2025 - 2032 (USD Million)
TABLE 32. Nutrigenomics testing market, 2018 - 2024 (Units)
TABLE 33. Nutrigenomics testing market, 2025 - 2032 (Units)
TABLE 34. Skincare testing market, 2018 - 2024 (USD Million)
TABLE 35. Skincare testing market, 2025 - 2032 (USD Million)
TABLE 36. Skincare testing market, 2018 - 2024 (Units)
TABLE 37. Skincare testing market, 2025 - 2032 (Units)
TABLE 38. Others market, 2018 - 2024 (USD Million)
TABLE 39. Others market, 2025 - 2032 (USD Million)
TABLE 40. Others market, 2018 - 2024 (Units)
TABLE 41. Others market, 2025 - 2032 (Units)
TABLE 42. Targeted analysis market, 2018 - 2024 (USD Million)
TABLE 43. Targeted analysis market, 2025 - 2032 (USD Million)
TABLE 44. Single nucleotide polymorphism (SNP) chips market, 2018 - 2024 (USD Million)
TABLE 45. Single nucleotide polymorphism (SNP) chips market, 2025 - 2032 (USD Million)
TABLE 46. Whole genome sequencing [WGS] market, 2018 - 2024 (USD Million)
TABLE 47. Whole genome sequencing [WGS] market, 2025 - 2032 (USD Million)
TABLE 48. Online platforms market, 2018 - 2024 (USD Million)
TABLE 49. Online platforms market, 2025 - 2032 (USD Million)
TABLE 50. Over-the-counter market, 2018 - 2024 (USD Million)
TABLE 51. Over-the-counter market, 2025 - 2032 (USD Million)